We analyzed here the clinical efficacy of mRNA-based coronavirus disease 2019 (COVID-19) vaccines among Italian children aged 5-11 years using data published by the National Institute of Health. Vaccination status was associated with a reduced risk of COVID-19 related hospitalizations and ICU admissions, which were 41% (odds ratio, 0.59; 95%CI, 0.46-0.77) and 68% (odds ratio, 0.32; 95%CI, 0.04-2.63) lower in children who completed the vaccination cycle <120 days compared to the unvaccinated matched population.

Real-world effectiveness of COVID-19 vaccination among children in Italy

Mattiuzzi, Camilla;Lippi, Giuseppe
2022-01-01

Abstract

We analyzed here the clinical efficacy of mRNA-based coronavirus disease 2019 (COVID-19) vaccines among Italian children aged 5-11 years using data published by the National Institute of Health. Vaccination status was associated with a reduced risk of COVID-19 related hospitalizations and ICU admissions, which were 41% (odds ratio, 0.59; 95%CI, 0.46-0.77) and 68% (odds ratio, 0.32; 95%CI, 0.04-2.63) lower in children who completed the vaccination cycle <120 days compared to the unvaccinated matched population.
COVID-19, vaccination, children
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11562/1065235
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 2
social impact